# US 2010/0168034 A1 · Peptide having cell membrane penetrating activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168034 A1
- Document ID: US20100168034A1
- Status: Published application
- Kind: A1
- Application number: 12/280,077
- Filed: 2007-02-20
- Published: 2010-07-01
- Earliest claimed: 2006-02-20
- Assignees: Ewha University-Industry Collaboration Foundation
- Inventors: Kyunglim Lee; Moonhee Kim; Miyoung Kim; Youngjoo Kwon
- Web page: https://patentgrep.com/patent/US20100168034A1

## CPC

- A61K 47/64: Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65)
- A61K 47/65: Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A61K 48/0008: {characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 7/06: having 5 to 11 amino acids
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/435: from animals; from humans
- C07K 14/46: from vertebrates
- C07K 14/47: from mammals
- C07K 16/18: against material from animals or humans
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides a peptide having cell membrane penetrating activity, a transmembrane carrier comprising the peptide having cell membrane penetrating activity as an effective component, a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance, a transfection kit comprising the peptide having cell membrane penetrating activity and the target substance, use of the peptide having cell membrane penetrating activity for the manufacture of a transmembrane complex, use of the transmembrane complex for the manufacture of a medicament, and a method for delivering a target substance into cell interior which comprises administrating to a subject with a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance to induce transduction of the transmembrane complex into cell interior. The peptide having cell membrane penetrating activity of the present invention has a prominent penetrating efficiency as compared with the activities of prior TAT-derived peptides and so the peptide has applications on intracellular delivery in various research fields as well as on therapeutics of specific diseases where targeting of drugs is required at high efficiency. Accordingly, the peptide having cell membrane penetrating activity, the transmembrane complex consisting of the peptide combined with a target substance and the method for delivering a target substance into cell interior using the transmembrane complex of the present invention are very useful as drug delivery systems.

## Claims

### Claim 1

A peptide having cell membrane penetrating activity, composed of the following amino acid sequence:
R1-R2-R3-R4-R5-R6-R7-R8-R9-R10
In the above formula,
R1 may be deleted or one amino acid selected from M, A, Q, C, F, L or W,
R2 may be deleted or one amino acid selected from I or A,
R3 may be one amino acid selected from I or A,
R4 may be one amino acid selected from Y, A, F, S or R,
R5 may be one amino acid selected from R, A or K,
R6 may be one amino acid selected from D, A, I or R,
R7 may be deleted or one amino acid selected from L, K, A, E or R,
R8 may be deleted or one amino acid selected from I, K or A,
R9 may be deleted or one amino acid selected from A, S, E, Y or T,
R10 may be deleted or one amino acid selected from A, H, K or E, and
if R10 is K or H, the amino acid(s) selected from K, KK, R, RR or HH may be added thereto.

### Claim 2 (depends on 1)

The peptide having cell membrane penetrating activity according to claim 1, wherein the amino acid sequence is SEQ ID No.: 1

### Claim 3 (depends on 1)

The peptide having cell membrane penetrating activity according to claim 1, wherein the amino acid sequence is one selected from SEQ ID No.: 2, SEQ ID No.: 3, SEQ ID No.: 4, SEQ ID No.: 5, SEQ ID No.: 6, SEQ ID No.: 7 or SEQ ID No.: 13.

### Claim 4 (depends on 1)

The peptide having cell membrane penetrating activity according to claim 1, wherein the amino acid sequence is one selected from SEQ ID No.: 20, SEQ ID No.: 21, SEQ ID No.: 22, SEQ ID No.: 23, SEQ ID No.: 24, SEQ ID No.: 25, SEQ ID No.: 26, SEQ ID No.: 27, SEQ ID No.: 28, SEQ ID No.: 29, SEQ ID No.: 30, SEQ ID No.: 31, SEQ ID No.: 32, SEQ ID No.: 33, SEQ ID No.: 34, SEQ ID No.: 35, SEQ ID No.: 36, SEQ ID No.: 37, SEQ ID No.: 38, SEQ ID No.: 39, SEQ ID No.: 40, SEQ ID No.: 41, SEQ ID No.: 42, SEQ ID No.: 43, SEQ ID No.: 44, SEQ ID No.: 45, SEQ ID No.: 46, SEQ ID No.: 47, SEQ ID No.: 48, SEQ ID No.: 49, SEQ ID No.: 50, SEQ ID No.: 51, SEQ ID No.: 52, SEQ ID No.: 53 or SEQ ID No.: 54.

### Claim 5 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 22.

### Claim 6 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 26.

### Claim 7 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 27.

### Claim 8 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 31.

### Claim 9 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 32.

### Claim 10 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 33.

### Claim 11 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 34.

### Claim 12 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 35.

### Claim 13 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 36.

### Claim 14 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 37.

### Claim 15 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 38.

### Claim 16 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 39.

### Claim 17 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 40.

### Claim 18 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 41.

### Claim 19 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 42.

### Claim 20 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 43.

### Claim 21 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 44.

### Claim 22 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 45.

### Claim 23 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 46.

### Claim 24 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 47.

### Claim 25 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 48.

### Claim 26 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 49.

### Claim 27 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 50.

### Claim 28 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 51.

### Claim 29 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 52.

### Claim 30 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 53.

### Claim 31 (depends on 4)

The peptide having cell membrane penetrating activity according to claim 4, wherein the amino acid sequence is SEQ ID No.: 54.

### Claim 32 (depends on 1)

A transmembrane carrier comprising the peptide having cell membrane penetrating activity according to claim 1 as an effective component.

### Claim 33 (depends on 1)

A transmembrane complex consisting of the peptide having cell membrane penetrating activity according to claim 1 combined with a target substance.

### Claim 34 (depends on 33)

The transmembrane complex of claim 33, wherein the target substance is one or more selected from nucleic acid, drug, chemical compound, carbohydrate, lipid, glycolipid, enzyme, regulating factor, growth factor or antibody.

### Claim 35 (depends on 1)

A transfection kit comprising the peptide having cell membrane penetrating activity according to claim 1 and a target substance.

### Claim 36 (depends on 35)

The transfection kit of claim 35, wherein the transfection kit further comprises a binding factor combining the peptide with the target substance.

### Claim 37 (depends on 1)

Use of the peptide having cell membrane penetrating activity according to claim 1 for the manufacture of a transmembrane complex.

### Claim 38 (depends on 1)

A method for preparing a transmembrane complex by combining a target substance with the peptide having cell membrane penetrating activity according to claim 1.

### Claim 39 (depends on 1)

Use of a transmembrane complex consisting of the peptide having cell membrane penetrating activity according to claim 1 combined with a target substance for the manufacture of a medicament.

### Claim 40 (depends on 1)

A method for manufacturing a medicament which comprises mixing a transmembrane complex consisting of the peptide having cell membrane penetrating activity according to claim 1 combined with a target substance, with a pharmaceutically acceptable carrier.

### Claim 41 (depends on 1)

A method for delivering a target substance into cell interior which comprises administrating to a subject with a transmembrane complex consisting of the peptide having cell membrane penetrating activity according to claim 1 combined with a target substance to induce transduction of the transmembrane complex into cell interior.

### Claim 42

A nucleic acid cording one amino acid sequence selected from SEQ ID No.: 1, 2, 22, 26, 27, or 31-54.

### Claim 43 (depends on 42)

The nucleic acid of claim 42, wherein the nucleic acid is one selected from SEQ ID No.: 17, 18, or 55-81 respectively.
